Oxford University began COVID-19 test for individuals without symptoms
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
-
-
Mammoth Biosciences announced agreements targeting high-throughput CRISPR-based SARS CoV-2 test
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
-
OncoSec announced FDA clearance of IND application for phase 1 clinical trial of CORVax12 vaccine candidate for COVID-19
On Oct. 29, 2020, OncoSec Medical announced that the FDA had approved the Investigational New Drug (IND) application…
-
AquaBounty announced Mayfield, Kentucky as location for planned 10,000 metric ton salmon farm
On Oct. 29, 2020, AquaBounty Technologies announced that it had identified Mayfield, Kentucky as the potential location for…
-
PerkinElmer COVID-19 test kit receives FDA Emergency Use Authorization for sample pooling
On Oct. 29, 2020, PerkinElmer announced that the FDA had issued Emergency Use Authorization (EUA) to allow sample…
-
Moderna partnered with Takeda and Government of Japan to supply 50 million doses of mRNA vaccine against COVID-19
On Oct. 29, 2020, Takeda Pharmaceutical announced that it would import and distribute 50 million doses of Moderna’s…
-
Emulate collaborated with FDA to apply lung-chip to evaluate safety of COVID-19 vaccines
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…
-
UC Berkeley launched pop-up lab to monitor Bay Area sewage for COVID-19
On Oct. 29, 2020, the University of California, Berkeley (UC Berkeley) announced that it had launched a new…
-
CVS Health expanded COVID-19 testing services with 1,000 rapid-result test sites
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
-
Data for Lilly’s bamlanivimab (LY-CoV555) in COVID-19 outpatients published in NEJM
On Oct. 28, 2020, Eli Lilly announced the New England Journal of Medicine had published data from the…
-
Biotechnology | COVID-19 | FDA | Therapeutics
Lilly announced agreement with US government to supply 300,000 vials of investigational neutralizing antibody bamlanivimab to fight COVID-19
On Oct. 28, 2020, Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials…
-
First patients treated with the worldﾒs smallest heart pump, the 9Fr Impella ECP
On Oct. 28, 2020, Abiomed announced the first two patients were treated with the Impella ECP expandable percutaneous…
-
Regeneron’s COVID-19 outpatient trial demonstrated that REGN-COV2 antibody significantly reduced virus levels
On Oct. 28, 2020, Regeneron announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the…
-
NIH scientists discovered key pathway in lysosomes that coronaviruses use to exit cells
On Oct. 28, 2020, researchers at the NIH announced that they had discovered a biological pathway that the…
-
Novartis announced collaboration with Molecular Partners to develop DARPinﾮ therapies against COVID-19
On Oct. 28, 2020, Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and…
-
UNMC VA study found contaminants may increase risk of rheumatoid arthritis
On Oct. 28, 2020, researchers at the University of Nebraska Medical Center (UNMC) reported the results of a…
-
Aspirin use best for those with high coronary calcium, low risk of bleeding
On Oct. 28, 2020, University of Texas (UT) Southwestern scientists reported that an X-ray test commonly used to…
-
Seagen announced closing of $1.0 billion stock sale to Merck
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
-
Postpartum depression may persist three years after giving birth
On Oct. 27, 2020, a National Institutes of Health (NIH) study of 5,000 women found that approximately 1…
-
Aurinia announced European trial to evaluate antiviral activity of Voclosporin in kidney transplant recipients with COVID-19
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Scientists used clues in the human genome to discover new inflammatory syndrome
On Oct. 27, 2020, researchers from the National Institutes of Health (NIH) announced they had discovered a new…
-
Nektar Therapeutics announced phase 1b clinical study to evaluate empegaldesleukin for treatment of patients with COVID-19
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
-
UK MHRA began rolling review of Moderna’s mRNA COVID-19 vaccine
On Oct. 27, 2020, Moderna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
-
Additional COVID-19 related genes ﾖ both helpful and harmful ﾖ revealed in massive screen
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
-
Novavax provided phase 3 COVID-19 vaccine clinical development update
On Oct. 27, 2020, Novavax announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19…
-
CHF Solutions announced deployment of Aquadex Systems to hospitals in the s to treat COVID-19 patients
On Oct. 27, 2020, CHF Solutions announced that it had shipped Aquadexﾙ product to medical facilities in Tennessee…
-
Antibodies co-invented by Scripps Research and IAVI developed as a potential COVID-19 therapy
On Aug. 27, 2020, immunologists at Scripps Research, in partnership with colleagues at the IAVI Neutralizing Antibody Center,…
-
Moderna announced supply agreement with Qatar for mRNA vaccine against COVID-19
On Oct. 26, 2020, Moderna announced a supply agreement with the Ministry of Public Health of Qatar for…
-
ContraFect initiated expanded access to Exebacase for treatment of MRSA bloodstream infections in COVID-19 patients
On Oct. 26, 2020, ContraFect announced that it had initiated an expanded access program to provide exebacase for…
-
Bayer acquired Asklepios BioPharmaceutical for $40 billion
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a North Carolina-headquartered biopharmaceutical company specialized in…
